SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-115454
Filing Date
2024-04-26
Accepted
2024-04-26 06:11:49
Documents
7
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d938219ddef14a.htm DEF 14A 441514
2 GRAPHIC g938219dsp002.jpg GRAPHIC 169216
3 GRAPHIC g938219dsp003.jpg GRAPHIC 110000
4 GRAPHIC g938219g13n02.jpg GRAPHIC 114582
5 GRAPHIC g938219g21h26.jpg GRAPHIC 35476
6 GRAPHIC g938219g30a88.jpg GRAPHIC 21774
7 GRAPHIC g938219g89a89.jpg GRAPHIC 27680
  Complete submission text file 0001193125-24-115454.txt   1095080
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39941 | Film No.: 24878432
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)